Dahide 8mg,16mg and 24mg TABLETS
PDF Leaflet Revision Date: 13 March 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of vertigo associated with Mu00e9n iu00e8reu2019s syndrome.
Dosage (summary)
Initially 16 mg three times daily; maintenance 24-48 mg daily in divided doses.
Special Populations
- Elderly
- Patients with bronchial asthma
- Patients with a history of peptic ulcers
Pregnancy & Breastfeeding
Not recommended during pregnancy and lactation due to insufficient data.
Key Drug Interactions
- Avoid concomitant use with antihistamines
Contraindications
- Hypersensitivity to ingredients
- Active peptic ulcer
- Phaeochromocytoma
Common side effects
- Gastro-intestinal disturbances
- Headache
- Hypersensitivity reactions
Counselling Points
- Take with meals to reduce gastrointestinal disturbances
- Report any hypersensitivity reactions
Serious warnings
- Caution in asthmatic patients
- Caution in patients with peptic ulcer history
Important Disclaimer
The Dahide 8mg,16mg and 24mg TABLETS professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
